Sylvia Brunner
9Patents
1h-index
15Co-inventors
44Inventor score
Filing activity: Aug 8, 2008 → Jan 11, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8618046B2 | Treatment of atherosclerosis with cholesterol ester transport protein mimotopes | Human Necessities | 1 | Active |
| US9085636B2 | CETP fragments | Chemistry; Metallurgy | 0 | Active |
| US9220762B2 | PCSK9 peptide combination vaccine and method of use | Chemistry; Metallurgy | 0 | Active |
| US9533030B2 | Vaccine capable of inducing formation of antibodies directed to proprotein convertase subtilisin/kexin type 9 (PCSK9) in vivo | Human Necessities | 0 | Active |
| US9669079B2 | PCSK9 peptide combination vaccine and method of use | Chemistry; Metallurgy | 0 | Active |
| US9999659B2 | Treatments using a peptide and/or vaccine | Human Necessities | 0 | Active |
| US10933123B2 | Peptide vaccines usable for hypercholesterolemia related diseases | Human Necessities | 0 | Active |
| US11980657B2 | Peptide vaccines for hypercholesterolemia related diseases | Human Necessities | 0 | Active |
| US10004791B2 | Peptide vaccines against PCSK9 | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.